Use of Biomarkers in the Management of Heart Failure-Reference-Cited by-同舟云学术

Use of Biomarkers in the Management of Heart Failure

Published:2003-03-11 Issue:9 Volume:107 Page:1231-1233
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Bozkurt Biykem¹,Mann Douglas L.¹

Affiliation:

1. From the Winters Center for Heart Failure Research, Department of Medicine, Baylor College of Medicine, and the Medical Care Line, Houston Veterans Administration Medical Center, Houston, Tex; and The Methodist Hospital, Houston, Tex.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000057608.97285.20

Reference12 articles.

1. Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

2. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure;Circulation;2018-09-11

2. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines;Current Cardiology Reports;2018-04-17

3. Transcriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy;Physiological Genomics;2017-07-01

4. In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio;Experimental and Therapeutic Medicine;2017-06-27

5. Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study;Biomarkers;2016-11-09